We are live on ! Find out more
CC

Colrain Capital Portfolio holdings

AUM $295M
1-Year Est. Return 82.72%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+82.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$55.6M
AUM Growth
+$7.77M
Cap. Flow
+$1.5M
Cap. Flow %
2.69%
Top 10 Hldgs %
63.04%
Holding
23
New
1
Increased
5
Reduced
12
Closed

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.74M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.12M
3
VST icon
Vistra
VST
+$1.11M
4
ABBV icon
AbbVie
ABBV
+$338K
5
LHX icon
L3Harris
LHX
+$309K

Top Sells

Rank Stock Value
1
MOS icon
The Mosaic Company
MOS
+$1.17M
2
CI icon
Cigna
CI
+$375K
3
AAPL icon
Apple
AAPL
+$324K
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$292K
5
CMCSA icon
Comcast
CMCSA
+$280K

Sector Composition

Rank Sector Weight
1 Healthcare 21.87%
2 Technology 14.45%
3 Materials 11.42%
4 Communication Services 10.32%
5 Consumer Staples 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOS icon
1
The Mosaic Company
MOS
$8.22B
$5.21M 9.37%
163,292
-34,518
-17% -$1.17M
HES
2
DELISTED
Hess
HES
$4.34M 7.82%
49,750
VST icon
3
Vistra
VST
$50.1B
$3.92M 7.06%
211,500
+64,250
+44% +$1.11M
CVS icon
4
CVS Health
CVS
$124B
$3.75M 6.75%
45,000
-500
-1% -$40.9K
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$4.14T
$3.6M 6.48%
29,500
-2,500
-8% -$292K
IP icon
6
International Paper
IP
$19.7B
$2.97M 5.35%
51,216
-2,640
-5% -$151K
AAPL icon
7
Apple
AAPL
$4.67T
$2.94M 5.3%
21,500
-2,500
-10% -$324K
WMT icon
8
Walmart Inc
WMT
$850B
$2.82M 5.07%
6,000
-750
-11% -$34.9K
MSFT icon
9
Microsoft
MSFT
$3.71T
$2.8M 5.04%
10,345
-550
-5% -$140K
CI icon
10
Cigna
CI
$74.7B
$2.67M 4.8%
11,250
-1,500
-12% -$375K
ABBV icon
11
AbbVie
ABBV
$453B
$2.43M 4.37%
21,550
+3,000
+16% +$338K
LHX icon
12
L3Harris
LHX
$47.8B
$2.3M 4.13%
10,625
+1,435
+16% +$309K
QCOM icon
13
Qualcomm
QCOM
$180B
$2.29M 4.11%
16,000
BG icon
14
Bunge Global
BG
$22.8B
$2.23M 4.01%
28,500
-500
-2% -$42.2K
CMCSA icon
15
Comcast
CMCSA
$94B
$2.14M 3.85%
37,500
-5,000
-12% -$280K
C icon
16
Citigroup
C
$231B
$2.09M 3.76%
29,575
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$138B
$1.67M 3.01%
+8,300
New +$1.74M
MDT icon
18
Medtronic
MDT
$120B
$1.44M 2.58%
11,500
-2,100
-15% -$264K
BRK.B icon
19
Berkshire Hathaway Class B
BRK.B
$1.08T
$1.43M 2.57%
5,150
+4,000
+348% +$1.12M
NEM icon
20
Newmont
NEM
$135B
$1.14M 2.05%
18,000
+1,500
+9% +$101K
GDX icon
21
VanEck Gold Miners ETF
GDX
$30.7B
$968K 1.74%
28,500
JPM icon
22
JPMorgan Chase
JPM
$953B
$233K 0.42%
1,500
UNH icon
23
UnitedHealth
UNH
$356B
$200K 0.36%
500
-250
-33% -$99.7K

Similar funds

Colrain Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Colrain Capital held 23 positions worth $55.6M, up 16% from $47.8M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 4.3%. Colrain Capital opened 1 new position and made no exits, leaving the 23-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Materials.

  • Colrain Capital's largest Q2 2021 buy was Vertex Pharmaceuticals: 8,300 shares worth $1.67M.
  • Colrain Capital added most to Berkshire Hathaway Class B in Q2 2021, an estimated $1.12M increase.
  • Colrain Capital's biggest Q2 2021 reduction was The Mosaic Company, cutting an estimated $1.17M.
  • Colrain Capital's ten largest holdings make up 63% of its $55.6M portfolio in Q2 2021.
  • Colrain Capital opened 1 new position and closed 0 in Q2 2021.
  • Colrain Capital's portfolio value rose 16% quarter-over-quarter to $55.6M.

Based on Colrain Capital's 13F filing for Q2 2021, filed 13 Aug 2021.